Login to Your Account

$240M a 'realistic' final target

Truffle Capital's first closing raises $102M for biotech and med-tech investments

By Nuala Moran
Staff Writer

Friday, January 12, 2018

LONDON – Truffle Capital announced the $102 million first closing of its new Biomedtech fund and said it is in line to reach the final target of $240 million in 2018.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription